TPSLP(pT)PP(pT)REPK-(Lys-13C6,15N2) TFA
TPSLP(pT)PP(pT)REPK-(Lys-13C6,15N2) TFA is the 13C- and 15N-labeled TPSLP(pT)PP(pT)REPK-(Lys) TFA.
For research use only. We do not sell to patients.
- Formula: C5713C6H107N1515N2O26P2.xC2HF3O2
- Molecular Weight:1588.51 (free acid)
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Application
1. This compound can be used as a tracer
2. This compound can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.
Chemical Information
-
Molecular Weight 1588.51 (free acid)
-
Formula C5713C6H107N1515N2O26P2.xC2HF3O2
-
SMILES
O=C([C@@H](N)[C@@H](C)O)N1[C@H](C(N[C@H](C(N[C@H](C(N2[C@H](C(N[C@H](C(N3[C@H](C(N4[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N5[C@H](C([15NH][13C@H]([13C](O)=O)[13CH2][13CH2][13CH2][13CH2][15NH2])=O)CCC5)=O)CCC(O)=O)=O)CCCNC(N)=N)=O)[C@@H](C)OP(O)(O)=O)=O)CCC4)=O)CCC3)=O)[C@@H](C)OP(O)(O)=O)=O)CCC2)=O)CC(C)C)=O)CO)=O)CCC1.O=C(C(F)(F)F)O.[x]
-
Sequence
Thr-Pro-Ser-Leu-Pro-{p-Thr}-Pro-Pro-{p-Thr}-Arg-Glu-Pro-{Lys-13C6,15N2}
-
Sequence Shortening
TPSLP-{p-Thr}-PP-{p-Thr}-REP-{Lys-13C6,15N2}
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)